Advertisement
UK markets close in 5 hours 37 minutes

  • FTSE 100

    8,083.04
    +38.23 (+0.48%)
     

  • FTSE 250

    19,797.78
    -1.94 (-0.01%)
     

  • AIM

    754.54
    -0.33 (-0.04%)
     

  • GBP/EUR

    1.1630
    +0.0002 (+0.02%)
     

  • GBP/USD

    1.2429
    -0.0023 (-0.19%)
     

  • Bitcoin GBP

    53,375.59
    +174.79 (+0.33%)
     

  • CMC Crypto 200

    1,430.96
    +6.86 (+0.48%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    83.04
    -0.32 (-0.38%)
     

  • GOLD FUTURES

    2,328.10
    -14.00 (-0.60%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,196.89
    +59.24 (+0.33%)
     

  • CAC 40

    8,126.38
    +20.60 (+0.25%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Top Ranked Momentum Stocks to Buy for December 30th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th:

HealthEquity, Inc. (HQY): This company that provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.

HealthEquity, Inc. Price and Consensus

HealthEquity, Inc. Price and Consensus
HealthEquity, Inc. Price and Consensus

HealthEquity, Inc. price-consensus-chart | HealthEquity, Inc. Quote

ADVERTISEMENT

HealthEquity’s shares gained 20.3% over the last one month above the S&P 500’s increase 4.1%. The company possesses a Momentum Score of B.

HealthEquity, Inc. Price

HealthEquity, Inc. Price
HealthEquity, Inc. Price

HealthEquity, Inc. price | HealthEquity, Inc. Quote

Sony Corporation (SNE): This company that designs, develops, produces, and sells electronic equipment, instruments, and devices for the consumer, professional, and industrial markets has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.

Sony Corporation Price and Consensus

Sony Corporation Price and Consensus
Sony Corporation Price and Consensus

Sony Corporation price-consensus-chart | Sony Corporation Quote

Sony’s shares gained 7.1% over the last one month. The company possesses a Momentum Score of B.

Sony Corporation Price

Sony Corporation Price
Sony Corporation Price

Sony Corporation price | Sony Corporation Quote

Bristol-Myers Squibb Company (BMY): This company that discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.

Bristol-Myers Squibb Company Price and Consensus

Bristol-Myers Squibb Company Price and Consensus
Bristol-Myers Squibb Company Price and Consensus

Bristol-Myers Squibb Company price-consensus-chart | Bristol-Myers Squibb Company Quote

Bristol-Myers Squibb’s shares gained 11.7% over the last one month. The company possesses a Momentum Score of A.

Bristol-Myers Squibb Company Price

Bristol-Myers Squibb Company Price
Bristol-Myers Squibb Company Price

Bristol-Myers Squibb Company price | Bristol-Myers Squibb Company Quote

Adaptive Biotechnologies Corporation (ADPT): This company that develops an immune medicine platform for the diagnosis and treatment of various diseases has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 55.3% over the last 60 days.

Adaptive Biotechnologies Corporation Price and Consensus

Adaptive Biotechnologies Corporation Price and Consensus
Adaptive Biotechnologies Corporation Price and Consensus

Adaptive Biotechnologies Corporation price-consensus-chart | Adaptive Biotechnologies Corporation Quote

Adaptive Biotechnologies’ shares gained 6.4% over the last one month. The company possesses a Momentum Score of B.

Adaptive Biotechnologies Corporation Price

Adaptive Biotechnologies Corporation Price
Adaptive Biotechnologies Corporation Price

Adaptive Biotechnologies Corporation price | Adaptive Biotechnologies Corporation Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sony Corporation (SNE) : Free Stock Analysis Report
 
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
 
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
 
Adaptive Biotechnologies Corporation (ADPT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research